Table 3 .
Outcomes associated with gynaecomastia referrals
| Number (%) | 2018 | 2019 | 2020 | Total |
|---|---|---|---|---|
| Total gynaecomastia referrals | 90 | 83 | 98 | 271 |
| Mean (SD) age in years | 51 (23.1) | 45 (20.0) | 47 (21.2) | 48 (21.4) |
| Bilateral | 49 (54.4) | 43 (51.8) | 65 (66.3) | 157 (57.9) |
| Left | 24 (26.7) | 23 (27.7) | 25 (25.5) | 72 (26.6) |
| Right | 17 (18.9) | 17 (20.5) | 8 (8.2) | 42 (15.5) |
| Aetiology of gynaecomastia | ||||
| Drug-induced | 39 (43.3) | 24 (28.9) | 33 (33.7) | 96 (35.4) |
| Pubertal | 5 (5.6) | 9 (10.8) | 4 (4.1) | 18 (6.6) |
| Endocrine | 1 (1.1) | 4 (4.8) | 4 (4.1) | 9 (3.3) |
| Urology | 0 (0) | 1 (1.2) | 1 (1.0) | 2 (0.7) |
| Alcohol or liver disease | 4 (4.4) | 7 (8.4) | 7 (7.1) | 18 (6.6) |
| Senile | 3 (3.3) | 7 (8.4) | 4 (4.1) | 14 (5.2) |
| Idiopathic | 38 (42.2) | 31 (37.3) | 45 (45.9) | 114 (42.2) |
| Total investigations | ||||
| Bloods | 41 (45.6) | 35 (42.2) | 39 (39.8) | 115 (42.4) |
| Ultrasound | 56 (62.2) | 39 (47.0) | 47 (48.0) | 142 (52.4) |
| Mammogram | 37 (41.1) | 33 (39.8) | 42 (42.9) | 112 (41.3) |
| Biopsy | 1 (1.1) | 0 (0) | 4 (4.1) | 5 (1.8) |
| Nil | 4 (4.4) | 11 (13.3) | 6 (6.1) | 21 (7.7) |
| Treatment | ||||
| Reassure and discharge | 79 (87.8) | 75 (90.4) | 89 (90.9) | 243 (89.7) |
| Onward referral | 1 (1.1) | 3 (3.6) | 5 (5.1) | 9 (3.3) |
| Medical treatment | 6 (6.7) | 1 (1.2) | 2 (2.0) | 9 (3.3) |
| Surgical treatment | 4 (4.4) | 4 (4.8) | 2 (2.0) | 10 (3.7) |